中国医学创新Issue(18)：17-19,20,4.DOI:10.3969/j.issn.1674-4985.2015.18.006
替加环素、多粘菌素和头孢哌酮舒巴坦对多重耐药鲍曼不动杆菌体外抗菌活性的研究
Study on Antibacterial Activity of Bacteria in Vitro of Tigecycline,Polymyxin and Cefoperazone Sulbactam Against Multi Drug Resistant Bauman Acinetobacter
摘要
Abstract
Objective:To study the tigecycline,polymyxin B and cefoperazone sulbactam motionless bacilli in vitro antibacterial activity against multi drug resistant Bauman acinetobacter,to provide the basis for clinical rational drug use. Method:The clinical microbiology laboratory bacteria cultures of drug sensitivity test specimens were selected in our hospital from January 2013 to June 2014,the results identified by the multi drug resistance of 50 strains of Bauman Acinetobacter,drug sensitivity disk diffusion method were used to tigecycline,polymyxin and cefoperazone sulbactam for in vitro drug sensitivity test. Result:Tigecycline against multi drug resistant acinetobacter keep Bauman sensitivity of 100%,polymyxin B and moderate sensitivity was 67%,resistant to cefoperazone sulbactam rate was 73%.Conclusion:Tigecycline and polymyxin against multi drug resistant Bauman acinetobacter have high antibacterial activity,is one of the best drug bacillus for the treatment of multi drug resistant acinetobacter Bauman.关键词
替加环素/多粘菌素/多重耐药鲍曼不动杆菌/体外抗菌活性Key words
Tigecycline/Polymyxin/Multidrug resistance of Bauman acinetobacter/Antibacterial activity in vitro引用本文复制引用
王康椿,李满元,余小同,刁燕丽..替加环素、多粘菌素和头孢哌酮舒巴坦对多重耐药鲍曼不动杆菌体外抗菌活性的研究[J].中国医学创新,2015,(18):17-19,20,4.基金项目
2014年广东省建设中医药强省科研项目 （）
